Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

10662046001

Roche

β-Galactose Dehydrogenase S

suspension, ~80 units/mg protein (At 25 °C with galactose as the substrate.), pkg of 50 U

Synonym(s):

D-galactose:NAD+ 1-oxidoreductase

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Enzyme Commission number:
1.1.1.48 (BRENDA, IUBMB)
UNSPSC Code:
12352204

recombinant

expressed in E. coli

Quality Level

100

description

of Pseudomonas fluorescens from E. coli

form

suspension

specific activity

80 U/mg (Approximately 80 U/mg protein at +25°C with galactose as the substrate.)
~80 units/mg protein (At 25 °C with galactose as the substrate.)

packaging

pkg of 50 U

manufacturer/tradename

Roche

shipped in

wet ice

storage temp.

2-8°C

Related Categories

General description

D-galactose:NAD+ 1-oxidoreductase

Application

β-Galactose Dehydrogenase S has been used in the colorimetric microassay method to determine the level of galactose and galactose-1-phosphate in blood.

Quality

Contaminants: <0.01% ADH, <0.01% ß-galactosidase, <0.1% LDH, <0.05% NADH oxidase

Physical form

Suspension in 3.2 M ammonium sulfate solution, pH approximately 6

Other Notes

For life science research only. Not for use in diagnostic procedures.

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 1

Flash Point(F)

does not flash

Flash Point(C)

does not flash

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

Alkaline Phosphatase solution, from bovine (calf) intestine, 2&#160;units/&#956;g protein, optimum pH 7.5-9.5

Roche

APMB-RO

Alkaline Phosphatase

S Bandyopadhyay et al.
Human reproduction (Oxford, England), 18(10), 2031-2038 (2003-09-26)
The pathophysiological mechanisms underlying premature ovarian failure (POF) are largely unknown. Our objective was to develop a working animal model to explore the pathogenesis of POF. Since galactosaemic women eventually develop POF, we evaluated the potential of experimental galactose toxicity

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service